Login


TI Ref No : 518342577
Description : Tenders Are Invited For Agreement According To Section 130a (8) Sgb V I. V. M. Section 130c (1) Sgb V On The Active Ingredient Bevacizumab Gamma (lytenava?).agreement According To Section 130a (8) Sgb V I. V. M. Section 130c (1) Sgb V On The Active Ingred
Date : 2025-05-24
Deadline : 2025-08-22
Document Type : Contracts
View Details
Whats app